BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36002886)

  • 1. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
    He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
    BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer.
    Ji J; Chen R; Zhao L; Xu Y; Cao Z; Xu H; Chen X; Shi X; Zhu Y; Lyu J; Jiang J; Wang Y; Zhou T; He J; Wei X; Wu JB; Yang B; Wang F
    Mol Cancer; 2021 Mar; 20(1):58. PubMed ID: 33785037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
    Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
    Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
    Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
    Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
    Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma.
    Ding Y; Zeng M; Rao S; Chen C; Fu C; Zhou J
    Korean J Radiol; 2016; 17(6):853-863. PubMed ID: 27833401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatic Analysis and Clinical Case Studies Identify CD276 as a Promising Diagnostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Zhang Z; Xu J; Song Z; Zhang J; Lin Y; Ouyang J
    Cancer Control; 2024; 31():10732748241250181. PubMed ID: 38669187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
    Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of a gene signature in clear cell renal cell carcinoma.
    Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
    J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
    Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles.
    Grützmann K; Salomo K; Krüger A; Lohse-Fischer A; Erdmann K; Seifert M; Baretton G; Aust D; William D; Schröck E; Thomas C; Füssel S
    Biol Direct; 2024 May; 19(1):38. PubMed ID: 38741178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
    Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
    Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.
    Wu X; Weng L; Li X; Guo C; Pal SK; Jin JM; Li Y; Nelson RA; Mu B; Onami SH; Wu JJ; Ruel NH; Wilczynski SP; Gao H; Covarrubias M; Figlin RA; Weiss LM; Wu H
    PLoS One; 2012; 7(5):e35661. PubMed ID: 22623952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma.
    Mlcochova H; Machackova T; Rabien A; Radova L; Fabian P; Iliev R; Slaba K; Poprach A; Kilic E; Stanik M; Redova-Lojova M; Svoboda M; Dolezel J; Vyzula R; Jung K; Slaby O
    Sci Rep; 2016 Aug; 6():31852. PubMed ID: 27549611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.